Genetic Testing Provides Clinically Valuable Insights for Adults With Epilepsy

Genetic testing provides actionable insights for adults with epilepsy. Among 2,008 individuals, the overall diagnostic yield was 10.9%, with even higher diagnostic yield among those with comorbid intellectual disability (16.0%) or pharmacoresistant epilepsy (13.5%).

Via Neurology: Genetics. Published online December 16, 2021.

https://ng.neurology.org/content/8/1/e650

Specialties